HRTS Strangle Strategy
HRTS (Tema Cardiovascular and Metabolic ETF), in the Financial Services sector, (Asset Management industry), listed on NASDAQ.
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
HRTS (Tema Cardiovascular and Metabolic ETF) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $56.0M, a beta of 0.65 versus the broader market, a 52-week range of 28.11-37.82, average daily share volume of 6K, a public-listing history dating back to 2023. These structural characteristics shape how HRTS etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.65 indicates HRTS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. HRTS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on HRTS?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
HRTS snapshot
As of August 14, 2026, spot at $37.12, ATM IV 19.70%, IV rank 6.93%, expected move 5.65%. The strangle on HRTS below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this strangle structure on HRTS specifically: HRTS IV at 19.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a HRTS strangle, with a market-implied 1-standard-deviation move of approximately 5.65% (roughly $2.10 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HRTS expiries trade a higher absolute premium for lower per-day decay. Position sizing on HRTS should anchor to the underlying notional of $37.12 per share and to the trader's directional view on HRTS etf.
HRTS strangle setup
The HRTS strangle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HRTS at $37.12 on that close, the first option leg uses a $39.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HRTS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HRTS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $39.00 | $0.31 |
| Buy 1 | Put | $35.00 | $0.20 |
HRTS strangle risk and reward
- Net Premium / Debit
- -$51.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$51.00
- Breakeven(s)
- $34.49, $39.51
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
HRTS strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on HRTS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$3,448.00 |
| $8.22 | -77.9% | +$2,627.37 |
| $16.42 | -55.8% | +$1,806.73 |
| $24.63 | -33.7% | +$986.10 |
| $32.84 | -11.5% | +$165.47 |
| $41.04 | +10.6% | +$153.17 |
| $49.25 | +32.7% | +$973.80 |
| $57.45 | +54.8% | +$1,794.43 |
| $65.66 | +76.9% | +$2,615.07 |
| $73.87 | +99.0% | +$3,435.70 |
When traders use strangle on HRTS
Strangles on HRTS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HRTS chain.
HRTS thesis for this strangle
The market-implied 1-standard-deviation range for HRTS extends from approximately $35.02 on the downside to $39.22 on the upside. A HRTS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current HRTS IV rank near 6.93% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on HRTS at 19.70%. As a Financial Services name, HRTS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HRTS-specific events.
HRTS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HRTS positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HRTS alongside the broader basket even when HRTS-specific fundamentals are unchanged. Always rebuild the position from current HRTS chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on HRTS?
- A strangle on HRTS is the strangle strategy applied to HRTS (etf). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With HRTS etf at $37.12 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed HRTS chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are HRTS strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the HRTS strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 19.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$51.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a HRTS strangle?
- The breakeven for the HRTS strangle priced on this page is roughly $34.49 and $39.51 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The HRTS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 5.65%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on HRTS?
- Strangles on HRTS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HRTS chain.
- How does current HRTS implied volatility affect this strangle?
- HRTS ATM IV is at 19.70% with IV rank near 6.93%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.